Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
cenicriviroc | c-c chemokine receptor type 2 | NA | Clinical trial target | TTD , DGIDB | Communicable Diseases[MeSHID:D003141] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Infection[MeSHID:D007239] HIV Infections[MeSHID:D015658] |
5.79 | phase 2 | unknown |
cenicriviroc | c-c chemokine receptor type 2 | NA | Clinical trial target | TTD , DGIDB | Communicable Diseases[MeSHID:D003141] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Infection[MeSHID:D007239] HIV Infections[MeSHID:D015658] |
5.79 | phase 2 | antagonist |
cenicriviroc | c-c chemokine receptor type 5 | NA | Successful target | TTD , DGIDB | Communicable Diseases[MeSHID:D003141] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Infection[MeSHID:D007239] HIV Infections[MeSHID:D015658] |
8.49 | phase 2 | antagonist |
cenicriviroc | c-c chemokine receptor type 5 | NA | Successful target | TTD , DGIDB | Communicable Diseases[MeSHID:D003141] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Infection[MeSHID:D007239] HIV Infections[MeSHID:D015658] |
8.49 | phase 2 | unknown |
click here to return to the previous page |